PMID: 9444449Jan 28, 1998Paper

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

Clinical Therapeutics
L VignatiP W Iversen

Abstract

A common treatment regimen for patients with either insulin-dependent diabetes mellitus (IDDM) or non-insulin-dependent diabetes mellitus (NIDDM) is a combination of rapid-acting insulin and intermediate-acting insulin administered twice each day. It is usually recommended that regular human insulin be injected 30 to 45 minutes before a meal. In practice, patients often inject regular human insulin closer to mealtime, causing a higher post-prandial serum glucose level and an increased potential for hypoglycemia in the postabsorptive period. Insulin lispro, a rapid-acting insulin analogue, is best injected just before a meal because of its more rapid absorption and shorter duration of action. In 707 randomized patients, 379 with IDDM and 328 with NIDDM, we studied the effect of twice-daily insulin lispro or regular human insulin in combination with NPH human insulin (isophane insulin) on premeal, 2-hour postprandial, and bedtime glycemic control. Assessments were based on the results of a seven-point blood glucose profile, the insulin dose (by formulation and time of administration), the incidence and frequency of hypoglycemic episodes, and the glycated hemoglobin value. Treatment with insulin lispro resulted in lower postprandi...Continue Reading

Citations

Aug 10, 2000·Indian Journal of Pediatrics·B Vaidyanathan, P S Menon
Jan 14, 2005·The New England Journal of Medicine·Irl B Hirsch
Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sumeet R SinghHeather Bennett
Oct 31, 2002·Clinical Pharmacokinetics·Paris Roach, James R Woodworth
Oct 22, 2002·Nihon rinsho. Japanese journal of clinical medicine·Ayako Matsuda
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Simon Heller
Jun 28, 2006·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Kate J E CarrEwan A Masson
Jul 1, 2016·The Cochrane Database of Systematic Reviews·Birgit FullertonFerdinand M Gerlach
Dec 18, 2018·The Cochrane Database of Systematic Reviews·Birgit FullertonFerdinand M Gerlach
Jul 16, 2005·Diabetes/metabolism Research and Reviews·P D HomeUNKNOWN European Insulin Glargine Study Group
Apr 21, 2006·The Cochrane Database of Systematic Reviews·A SiebenhoferT R Pieber
Feb 13, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Satish GargMartin Pfohl
Dec 25, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Antonio NicolucciMarco Orsini Federici
Oct 31, 2002·PharmacoEconomics·Christopher J Dunn, Greg L Plosker
Mar 6, 2007·Drugs·Dene SimpsonKatherine A Lyseng-Williamson
Aug 28, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·C PratoomsootW J Valentine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.